2020 Form 10-K
Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to_____
Download 2020 Form 10-K
Information
Domain:
Source:
Link to this page:
Documents from same domain
![[Product Monograph Template - Standard]](/cache/preview/1/3/7/9/6/d/a/a/thumb-13796daa617bc65beb773a3c01593750.jpg)
[Product Monograph Template - Standard]
s2.q4cdn.comNATESTO™ Product Monograph Page 6 of 39 Endocrine and Metabolism Androgens have been shown to alter glucose tolerance tests. Diabetics should be followed carefully and the insulin or oral hypoglycemic dosage adjusted accordingly (see Drug-Drug
Winning the future of retail
s2.q4cdn.com2015 Annual Report 1 Our framework for growth What is the strategic plan to drive Walmart’s continued growth in a changing retail environment
Code of Business Conduct and Ethics …
s2.q4cdn.comThis Code of Business Conduct and Ethics (this “Code”) is designed to reaffirm and promote Hyatt Hotels Corporation’s compliance with laws and ethical standards applicable in all jurisdictions in which Hyatt Hotels Corporation and its subsidiaries (collectively
A Letter from the President and Chief Executive …
s2.q4cdn.comA Letter from the President and Chief Executive Officer To My Fellow Shareholders: 2016 was a significant year for us. We celebrated our 30th anniversary as a …
VMWARE, INC. CORPORATE GOVERNANCE …
s2.q4cdn.comVMWARE, INC. CORPORATE GOVERNANCE GUIDELINES . ... The directors shall meet in executive session without the CEO in connection with each regularly
EUROPEAN ADDENDUM TO GLOBAL CODE OF …
s2.q4cdn.com1 When in doubt, contact the Ethics Helpline by visiting www.mastercard.ethicspoint.com for local dialing instructions. © 2016 MasterCard.
PRODUCT MONOGRAPH INCLUDING PATIENT …
s2.q4cdn.comNATESTO™ Product Monograph PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION NATESTO™ Testosterone nasal gel 4.5% w/w Androgens Acerus Pharmaceuticals SRL
GENERAL TERMS AND CONDITIONS PURCHASE …
s2.q4cdn.comGENERAL TERMS AND CONDITIONS PURCHASE ORDER 8447262.2 1. Acceptance of Entire Agreement: These Purchase Order General Terms and Conditions …
THE COMPANIES ACT 1981 OF BERMUDA SIGNET …
s2.q4cdn.com1.3 In these Bye-laws expressions referring to writing or its cognates shall, unless the contrary intention appears, include facsimile, printing, lithography, photography, electronic mail and other modes of representing words in visible form.
CONDENSED INTERIM CONSOLIDATED FINANCIAL …
s2.q4cdn.comCapstone Mining Corp. Condensed Interim Consolidated Statements of Changes in Equity Three Months Ended March 31, 2018 and 2017 (unaudited) (expressed in thousands of …
Related documents
FORM 10-Q 508 - SEC
www.sec.govForm 10-Q shall be used for quarterly reports under Section 13 or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 7 8m or 78o(d)), fi form pursuant to Rule 13a-13 or Rule 15d-13 shall be filed within the following period after the end of each of the first three
FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE …
berkshirehathaway.comform 10-q united states securities and exchange commission washington, d.c. 20549 (mark one) ☒ quarterly report pursuant to section 13 or 15(d) of the securities exchange act of 1934 for the quarterly period ended march 31, 2021 or ☐ transition report pursuant to section 13 or 15(d) of the securities exchange act of 1934
FORM 10-Q
d18rn0p25nwr6d.cloudfront.netWashington, D.C. 20549 _____ FORM 10-Q _____ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
WASHINGTON, D.C. 20549
investors.pepsico.comWASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 4, 2021 (36 weeks) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to
Table of Contents UNITED STATES SECURITIES AND …
investors.pepsico.comWASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 26, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to
FORM 10-K
s1.q4cdn.comunited states securities and exchange commission washington, d.c. 20549 form 10-k (mark one) þ annual report pursuant to section 13 or 15(d) of the securities exchange act of 1934 for the fiscal year ended may 31, 2019 or ¨ transition report pursuant to section 13 or 15(d) of the securities exchange act of 1934 for the transition period from to .
10-Q Q3 2021, 06.26
s2.q4cdn.comUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 26, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES …
FORM 10-Q
s22.q4cdn.comWashington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 0-23985 NVIDIA …
FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE …
www.berkshirehathaway.comFORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES …